We are looking for Partners / Distributors in USA 🇺🇸 for our Private Ultra Encrypted Communication Network “EchoLink” — 50% Commission ($9,000 per sale). Click Here
Daily Short Volume USKRYS

KRYS Short Pressure: 77 Days on Threshold List

Krystal Biotech (KRYS) has been flagged on the FINRA Reg SHO threshold list for 77 consecutive days, highlighting ongoing short-selling pressure.

By The Forensic Ledger Desk September 26, 20261 min read
Company
Krystal Biotech
Borrow Fee
0.3%
Short % Float
13.7%
Days to Cover
10.3

KRYS Short Selling Activity

Krystal Biotech (KRYS) continues to experience elevated short-selling pressure, remaining on the FINRA Reg SHO threshold list for 77 trading days. The stock currently shows a short interest of 13.7% of the float. While the borrow fee remains at 0.3%, the extended duration on the threshold list suggests that short sellers are maintaining a consistent presence in the stock. This data reflects daily short volume flow, which is a measure of daily selling pressure rather than the total open short interest reported by FINRA on a bi-monthly basis.

Source

Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Short Volume#US Equities

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets.

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.